Opthea announces decision to discontinue wet AMD trials
Source: SeekingAlpha
2025-03-31 01:55:53 ET
More on Opthea
- Opthea: Small Australian Company Aiming To Upend The Wet AMD Market
- Seeking Alpha’s Quant Rating on Opthea
- Historical earnings data for Opthea
- Financial information for Opthea
Read the full article on Seeking Alpha
For further details see:
Opthea announces decision to discontinue wet AMD trials
Opthea Limited
NASDAQ: OPT
OPT Trading
-2.05% G/L:
$3.41 Last:
3,025 Volume:
$3.48 Open:
OPT Latest News
OPT Stock Data
$583,100,698
167,235,331
N/A
12
537820%
Biotechnology & Life Sciences
Healthcare
AU
South Yarra
